Colossal Biosciences creates technologies for species restoration, critically endangered species protection, and the repopulation of critical ecosystems that support the continuation of life on Earth.
Unprecedented resource, created with Cedars-Sinai, to accelerate ALS research and drive development of targeted therapies globally NEW ORLEANS, [November 14, 2024] — In a landmark continuing ...
While the resulting iPSCs were the same quality, we suspect it’s likely to be different in human stem cells, and the viral defence protein is likely to be an important player in improving the quality ...
Researchers in Japan have developed a form of stem cell therapy that "reverses" paralysis. Though the treatment has only seen a 50% success rate so far, two of the four people who received it have ...
NEW ORLEANS--(BUSINESS WIRE)--In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results